MedPath

First Postoperative Day Review After Uneventful Phacoemulsification

Completed
Conditions
Phacoemulsification
Complications
BCVA
Registration Number
NCT01247155
Lead Sponsor
Veroia General Hospital
Brief Summary

The purpose of this randomized trial was to examine the value of the review on the first postoperative day after uneventful phacoemulsification cataract surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion criteria were the following:

i) intra-operative complications, such as posterior capsule rupture, vitreous loss, lost nucleus, zonule dehiscence and wound leak,

ii) inadequate social support for overnight care at home,

iii) severely limited visual potential in the fellow eye,

iv) uveitis or ocular trauma,

v) severe systemic diseases limiting activity,

vi) patients with learning disability or dementia.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Best corrected visual acuity
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

General Hospital of Veroia

🇬🇷

Veroia, Imathia, Greece

© Copyright 2025. All Rights Reserved by MedPath